1. Oclaro New Focus Photoreceiver Enables Cancer Detection Breakthrough

    N JOSE, Calif., June 2 /-- Oclaro, Inc. (NASDAQ: OCLR), has announced that its New Focus(TM) 2117 photoreceivers are underpinning an award winning breakthrough cancer detection system developed by scientists from Japan's Kitasato University. This unique optical demultiplexed (OD) optical coherence tomography (OCT) medical imaging system, received the 'Customer Application of the Year' Award from National Instruments. It delivers faster, more accurate tissue analysis with minimal stress on the patient when compared to existing techniques. The OD-OCT system incorporates 256 custom-designed New Focus 2117 photoreceivers enabling the high-speed gathering and interpretation of data, with the optical demultiplexers simultaneously collecting ...
    Read Full Article

    Login to comment.

  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. Topics Mentioned